Advertisement

Topics

Origo Acquisition Corporation Company Profile

12:48 EDT 23rd March 2019 | BioPortfolio

Origo Acquisition Corporation is a public investment vehicle formed for the purpose of effecting a merger, acquisition or similar business combination. Origo is led by Chief Executive Officer Edward J. Fred, Chief Financial Officer Jose M. Aldeanueva and Directors Stephen B. Pudles, Jeffrey J. Gutovich and Barry Rodgers. Origo’s securities are quoted on the Nasdaq stock exchange under the ticker symbols NASDAQ: OACQ, OACQU, OACQR and OACQW.


News Articles [541 Associated News Articles listed on BioPortfolio]

Orion Corporation: Managers' transactions - Olli Huotari

ORION CORPORATION         MANAGERS' TRANSACTIONS 4 March 2019 at 11.45 EET Orion Corporation: Managers' transactions - Olli Huotari Orion Corporation has received the ...

Orion Corporation: Managers' transactions - Virve Laitinen

ORION CORPORATION      MANAGERS' TRANSACTIONS 4 March 2019 at 11.45 EET Orion Corporation: Managers' transactions - Virve Laitinen Orion Corporation has received the f...

Orion Corporation: Managers' transactions - Satu Ahomäki

ORION CORPORATION     MANAGERS' TRANSACTIONS 4 March 2019 at 11.45 EET Orion Corporation: Managers' transactions - Satu Ahomäki   Orion Corporation has received the fo...

Orion Corporation: Managers' transactions - Christer Nordstedt

 ORION CORPORATION        MANAGERS' TRANSACTIONS 4 March 2019 at 11.45 EET Orion Corporation: Managers' transactions - Christer Nordstedt Orion Corporation has receiv...

Orion Corporation: Managers' transactions - Timo Lappalainen

ORION CORPORATION     MANAGERS' TRANSACTIONS 4 March 2019 at 11.45 EET Orion Corporation: Managers' transactions - Timo Lappalainen Orion Corporation has received...

Orion Corporation: Managers' transactions - Jari Karlson

ORION CORPORATION      MANAGERS' TRANSACTIONS 4 March 2019 at 11.45 EET Orion Corporation: Managers' transactions - Jari Karlson Orion Corporation has received the fol...

Orion Corporation: Managers' transactions - Markku Huhta-Koivisto

ORION CORPORATION         MANAGERS' TRANSACTIONS 4 March 2019 at 11.45 EET Orion Corporation: Managers' transactions - Markku Huhta-Koivisto Orion Corporation has rec...

Orion Corporation: Transfer of 47,279 own B shares on 1 March 2019

ORION CORPORATION      STOCK EXCHANGE RELEASE   1 MARCH 2019   at 19.10 EET             Orion Corporation: Transfer of 47,279 own B shares on 1 Ma...

PubMed Articles [332 Associated PubMed Articles listed on BioPortfolio]

Towards fast whole-body PET/MR: Investigation of PET image quality versus reduced PET acquisition times.

The trend towards faster acquisition protocols in whole-body positron emission tomography/magnetic resonance (PET/MR) arises the question of whether short PET data acquisition protocols in a whole-bod...

Tenofovir gel for prevention of herpes simplex virus type-2 acquisition: findings from the VOICE Trial.

Genital infection with herpes simplex virus type-2 (HSV-2) is common, and increases risk of HIV transmission and acquisition. Pericoital use of tenofovir (TFV) gel provided protection from HSV-2 acqui...

Second language acquisition effects of a primary physical education intervention: A pilot study with young refugees.

A physical education (PE) intervention for young refugees was designed combining physical activity within the context of primary PE games with second language learning activities in German. The interv...

Quantitative EMCD by use of a double aperture for simultaneous acquisition of EELS.

The weak signal strength in electron magnetic circular dichroism (EMCD) measurements remains one of the main challenges in the quantification of EMCD related EELS spectra. As a consequence, small vari...

Revisiting the bilingual lexical deficit: The impact of age of acquisition.

Whereas the cognitive advantages brought about by bilingualism have recently been called into question, the so-called 'lexical deficit' in bilinguals is still largely taken for granted. Here, we argue...

Clinical Trials [422 Associated Clinical Trials listed on BioPortfolio]

Virtual Task in Amyotrophic Lateral Sclerosis

Thirty individuals with ALS (18 men and 12 women, mean age 59 years, range 44-74 years), and 30 healthy controls matched for age and gender, participated. Individuals with ALS and from the...

Evaluation of MRI Sequences for Ultra-rapid Acquisition of Bile Ducts Images

The Institute of Imaged-Guided Surgery (IHU Strasbourg) has two clinical Magnetic Resonance Imaging (MRI) scanners, one with a 3T (3 Teslas) magnetic field used for diagnosis, the other wi...

Postural Balance of the Adult

Description of the geometrical configuration of the skeleton with regard to gravity line by patients suffering from spinal disorders that may induce postural troubles

Neuromodulation and Language Acquisition (Stage Ib)

The purpose of this study is to determine whether rivastigmine or pramipexol are effective in boosting semantic language acquisition in healthy subjects.

Improved Language Acquisition With Levodopa

The purpose of this study is to determine whether the non-daily administration of levodopa is effective in boosting semantic language acquisition in healthy subjects.

Companies [575 Associated Companies listed on BioPortfolio]

Origo Acquisition Corporation

Origo Acquisition Corporation is a public investment vehicle formed for the purpose of effecting a merger, acquisition or similar business combination. Origo is led by Chief Execu...

Origo Biotech Pty Ltd

Origo Biotech Pty Ltd is a plant biotechnology company that owns the exclusive worldwide rights to an impressive portfolio of proprietary gene technologies developed at the University of Queensland's ...

Origo Management

Origo Management provides specialized consulting services to the private equity and venture capital industry. Our clients include players from all stages of the private equity and venture capital valu...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Federal Street Acquisition Corp.

Federal Street Acquisition Corp. is a special purpose acquisition company sponsored by an affiliate of Thomas H. Lee Partners, L.P., formed for the purpose of effecting a merger, ...

More Information about "Origo Acquisition Corporation" on BioPortfolio

We have published hundreds of Origo Acquisition Corporation news stories on BioPortfolio along with dozens of Origo Acquisition Corporation Clinical Trials and PubMed Articles about Origo Acquisition Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Origo Acquisition Corporation Companies in our database. You can also find out about relevant Origo Acquisition Corporation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...


Corporate Database Quicklinks



Searches Linking to this Company Record